Seaport Global Advisors, LLC Supernus Pharmaceuticals, Inc. Transaction History

Seaport Global Advisors, LLC

  • $30.9 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$22.72 - $29.68 $184,645 - $241,209
8,127 Added 102.33%
16,069 $465,000
Q3 2023

Nov 14, 2023
BUY
$27.57 - $32.91 $92,249 - $110,116
3,346 Added 72.8%
7,942 $218,000
Q1 2023

May 23, 2023
SELL
$34.93 - $42.03 $119,844 - $144,204
-3,431 Reduced 42.74%
4,596 $166,000
Q4 2022

Feb 14, 2023
BUY
$31.09 - $37.88 $249,559 - $304,062
8,027 New
8,027 $286,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.96B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Seaport Global Advisors, LLC Portfolio

Follow Seaport Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seaport Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seaport Global Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email